BOOKMARK
  • Korean|
  • Chinese|
  • Japanese|
  • Vietnamese
본문내용 바로가기

Aju Business Daily

SEARCH
World's top technology exhibition CES 2021
  • ECONOMY
  • ENTERTAINMENT
  • IT
  • South Korea
  • North Korea
  • WORLD
  • SPORTS
  • LIFESTYLE
  • AUTO MOTIVE
  • OPINION
  • PEOPLE
  • MILITARY
Home > Health > article

LSK Global PS supports IVI's clinical trials of COVID-19 vaccine in S. Korea

Lim Chang-won Reporter(cwlim34@ajunews.com) | Posted : July 13, 2020, 13:32 | Updated : July 13, 2020, 13:32
  • 트위터
  • 페이스북
  • 웨이보

[Courtesy of LSK Global PS]


SEOUL -- LSK Global Pharma Services, a leading contract research
organization (CRO) in South Korea, partnered with a vaccine institute affiliated with the United Nations Development Programme to support clinical trials for a COVID-19 vaccine candidate developed by a U.S. biotechnology company.

Clinical trials are underway in South Korea to test the safety and efficacy of two vaccine candidates, including INO-4800 developed by Inovio Pharmaceuticals. The International Vaccine Institute (IVI), headquartered in Seoul, has won approval for clinical trials with Seoul National University Hospital.

"We are pleased to begin this clinical trial following the selection of LSK Global PS and taking the next steps toward the development of a COVID-19 vaccine, which has been eagerly awaited by people across the world,” IVI Director General Jerome Kim said in a statement. The phase 1/2 clinical trial of INO-4800, funded by the Coalition for Epidemic Preparedness Innovations (CEPI), is supported by the Korea National Institute of Health for laboratory analysis.

LSK Global PS said it would be responsible for general clinical operations, including project management, monitoring, data management and pharmacovigilance activities. "We are honored to conduct the first approved clinical trial of a COVID-19 vaccine in Korea and play our role as a leading CRO in addressing the growing expectations for a COVID-19 vaccine," said LSK Global PS president Young-Jack Lee.

"We remain committed to successfully completing clinical trials with the extensive experience and capabilities we have built through more than 130 global clinical trials including various trials of vaccines," Lee said. LSK Global PS has provided therapeutic area-specific services across oncology, cardiovascular disease and endocrinology.

  • Lim Chang-won Reporter
  • email : cwlim34@ajunews.com
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.
  • twitter
  • facebook
  • weibo
  • link copy
  • LIST
  • TOP

Related news

  • .40-year-old man becomes first volunteer to participate in COVID-19 vaccine test.
    40-year-old man becomes first volunteer to participate in CO…
  • .Seoul hospital to conduct clinical trial for Inovios COVID-19 DNA vaccine candidate .
    Seoul hospital to conduct clinical trial for Inovio's COVID-…
  • .Clinical trials to test ten treatment and two vaccine candidates in S. Korea.
    Clinical trials to test ten treatment and two vaccine candid…

Real Time Photo News

  • .Singer IU drops teaser image for upcoming full album.

    Singer IU drops teaser image for upcoming full album

  • .Cube Entertainment partners with web comics company to create online video content.

    Cube Entertainment partners with web comics company to create online video content

  • .Sci-fi film starring Song Joong-ki to be reelased on Netflix in February.

    Sci-fi film starring Song Joong-ki to be reelased on Netflix in February

  • .Actor Kim Soo-hyun to star in S. Korean remake of British TV drama series Criminal Justice.

    Actor Kim Soo-hyun to star in S. Korean remake of British TV drama series 'Criminal Justice'

  • .CJ ENM partners with NCSoft to roll out new digital content for global market.

    CJ ENM partners with NCSoft to roll out new digital content for global market

Latest News

more+

  • Singer IU drops teaser image for upcoming full album
  • Hyundai to complete construction of fuel cell production plant in China in 2022
  • Seoul builds solar power plant on idle land near urban expressway
  • Samsung showcases new Galaxy S21 smartphone models
  • Southern city launches joint research project to develop heavy-duty flying taxi drone
Aju Business Daily
  • ABOUT US
  • CONTACT US
  • PRIVACY STATEMENT
  • Copyright Policy

Address : Aju News Corporation LEEMA Building, 11th floor, 42, Jong-ro 1-gil, Jongno-gu, Seoul.    Mail : swatchsjp@ajunews.com

Copyright ⓒ 2016 By Ajunews Corporation, All Rights Reserved.

Mobile view